Semprus BioSciences Lands $18,000,000 Series B Round

  • Feed Type
  • Date
    12/13/2010
  • Company Name
    Semprus BioSciences
  • Mailing Address
    One Kendall Street Building 1400 1st Floor Cambridge, MA 02139
  • Company Description
    Semprus BioSciences is a venture-backed biotechnology company developing functional surfaces to prevent medical device complications. Our initial product development efforts are focused on the first implantable and permanently antimicrobial surface technology. The intellectual property comes from the MIT labs of Prof. Robert Langer and Prof. Greg Stephanopoulos, and part of this scientific research was featured in Nature.
  • Website
    http://www.semprusbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    Foundation Medical Partners
  • Venture Investor
    5AM Ventures
  • Venture Investor
    Pangaea Ventures

By posting a comment, you agree to our terms and conditions.